drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
New plans for 'world-class' mental health hospital
Plans have been submitted for a £750m new mental health hospital and medical research campus. Oxford Health NHS Foundation Trust said Warneford Park, in Headington, Oxford, would "benefit patients" and support advances in "mental health and brain science". It added the new hospital would have modern inpatient facilities, emphasising "patient wellness and therapeutic spaces that connect with nature". The original hospital, which opened in 1826, is thought to be the oldest inpatient unit still in use across the NHS.
Alzheimer's: At-Home Brainwave Test Offers Early Warning
Asimple at-home brainwave test can detect signs of memory impairment linked to Alzheimer's disease years before clinical diagnosis is typically possible. This feat has been demonstrated by researchers from the universities of Bath and Bristol, in the U.K., who trialed the 'Fastball EEG' technology in patients' homes for the first time. The three-minute "passive test"—which records electrical activity in the brain while participants view a stream of images—can reliably identify memory problems in people with Mild Cognitive Impairment (MCI)—a condition that can lead to Alzheimer's. "We're missing the first 10 to 20 years of Alzheimer's with current diagnostic tools. Fastball offers a way to change that—detecting memory decline far earlier and more objectively, using a quick and passive test," said study author George Stothart, a cognitive neuroscientist at Bath, in a statement.
OMED breath biopsy is transforming disease detection
The OMED Health Breath Analyzer is a handheld sensor system designed for at-home collection and analysis of hydrogen and methane gases produced by the fermentation of undigested sugars by the gut microbiome. This portable device provides accurate, on-demand breath testing, making it a practical tool for both clinical trials and research applications. Paired with a user-friendly smartphone app, the Breath Analyzer allows individuals to log food intake and symptoms alongside their breath readings. This integrated data can then be accessed by researchers for longitudinal monitoring of gut microbiome responses across a range of clinical study designs. To ensure accuracy comparable to in-clinic hydrogen methane breath tests (HMBT), the OMED Health team conducted extensive validation. This included building an in-house synthetic breath rig and benchmarking the device against a clinically established HMBT system.
Capol acquires Blue Pacific Flavors to enhance global ingredients innovation
Capol, a subsidiary of the Freudenberg Group and a manufacturer of confectionery coatings, has announced its acquisition of Blue Pacific Flavors, a player in natural and organic flavour systems. The deal aims to create a formidable global leader in food ingredients, enhancing innovation and product development capabilities across the food and beverage industry. The acquisition is poised to leverage the complementary strengths of both companies, facilitating accelerated innovation in flavours and coatings while expanding customer reach across North America, Europe and Asia. With this merger, Capol aims to position itself at the forefront of market trends in health, wellness and indulgence categories, responding to the evolving demands of consumers and businesses alike.
Industrial biotechnology company enabling enzyme-based processes Providing high-performance enzymes that enable cost reduction and bio-based production
Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturing. The funding includes a $2.8M seed round led by Endurance28 with participation from Stray Dog Capital, 1Flourish, Range Ventures, 10VC, and Amplify plus $3.2M in nondilutive funding from the U.S. National Science Foundation (NSF) through the Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications (NSF CFIRE) initiative and an SBIR Phase II award. With this investment, Cascade will expand delivery of its breakthrough biocatalysts, giving industrial partners higher performing enzymes that cut costs and unlock biobased production.
Intravenous Maintenance Dosing of Early Alzheimer's Disease Treatment “Lecanemab®” (Lecanemab) Receives Approval in China
Eisai Co., Ltd. (Headquarters: Tokyo, Representative Executive Officer and CEO: Haruo Naito, hereinafter referred to as “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, USA, CEO: Christopher A. Viehbacher, hereinafter referred to as ‘Biogen’) have announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the humanized anti-human soluble amyloid beta (Aβ) aggregate monoclonal antibody “Lecembi®” (Chinese product name: "乐 Viehbacher; hereinafter “Biogen”) announce that the National Medical Products Administration (NMPA) of China has approved the once-every-four-weeks intravenous (IV) maintenance infusion of the humanized anti-human soluble amyloid beta (Aβ) aggregate monoclonal antibody “Lecanemab®” (Chinese product name: “乐意保®”; generic name: lecanemab).
FDA grants 510(k) clearance for Cardiosense’s wearable sensor
The US Food and Drug Administration (FDA) has granted 510(k) clearance for CardioTag, Cardiosense’s multimodal, wearable sensor. Aimed at cardiac function monitoring, the device is said to capture high-fidelity electrocardiogram (ECG), seismocardiogram (SCG), and photoplethysmogram (PPG) signals. SCG is a technique that detects subtle chest wall vibrations linked to the heart’s mechanical activity.
Rethinking Adient Cell Culture for Scalable and Sustainable Biomanufacturing
This paper discusses the challenges and solutions related to the scalability and sustainability of Adient cell culture. Conventional T-flasks and roller bottles are not scalable, leading to increased labor costs and inconsistencies. Additionally, suspension culture using microcarriers may negatively impact cell behavior and product quality.New technologies maintain intercellular signaling and morphological consistency while improving labor efficiency and reproducibility. Sustainable technologies, such as biodegradable materials and additive manufacturing techniques, are gaining attention for their ability to reduce environmental impact while ensuring regulatory compliance. Going forward, scalable manufacturing processes and smart process integration will be essential.
Wearable Sleep Monitoring Device May Improve Detection of Sleep Disorders
A new wearable sleep monitoring device developed by a research team at Northwestern University can be attached to the base of the neck to more accurately measure patients' sleep and improve the detection of sleep disorders. The device collects data such as breathing, heart rate, and body temperature, and provides sleep scores and analysis results to patients' smartphones or tablets through the machine learning model LMA-SleepNet.Additionally, compared to traditional devices worn on the wrist or finger, this device can collect more sleep data and has the ability to accurately analyze breathing patterns. This study was published in the Proceedings of the National Academy of Sciences (PNAS).
From Sleep Tech to Health Check Integration: The Evolution of Vital Sensors Measuring Heart Rate and Breathing
The application areas for Sumitomo Riko's developed vital sensor “Monilife™ Wellness” are expanding. Following its initial introduction in capsule hotels in 2021, a new service combining sleep analysis and health checkups is scheduled to launch. This initiative, bridging sleep tech and preventive healthcare, is drawing significant attention. In August 2024, Nine Hours will install “Monilife Wellness” in all 70 beds at its new “Shinagawa Station Sleep Lab.” Cumulative installations have now surpassed 450 units. The sensor utilizes piezoelectric technology based on the flexible conductive rubber “Smart Rubber® (SR),” featuring a unique formulation balance that achieves both softness and conductivity.It detects minute vibrations from heartbeat and respiratory components without requiring wearable devices. Guests receive sleep measurement and analysis, later reviewing their condition via a report. Moving forward, Nine Hours and Kinki Health Center (KKC) will partner to launch a “Sleep Analysis + Health Checkup” service in Tokyo. Users will stay at the capsule hotel to collect sleep data, which will be combined with a subsequent health checkup for a comprehensive evaluation. This approach requires less effort than traditional testing and enables data collection in a natural state. The “Monilife” series is deployed for both medical and non-medical devices. It has been utilized in studies such as detecting worsening conditions in heart failure patients during home care and researching drowsiness warning signs for drivers. Sumitomo Riko, aiming to become a “leading company that continuously provides solutions to social issues, starting from the power of science and technology,” as stated in its management vision for its 100th anniversary in 2029, is poised to further accelerate its business expansion in the healthcare field.
MIT engineers develop electrochemical sensors for cheap, disposable diagnostics
Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such as influenza and HIV. These electrochemical sensors make use of a DNA-chopping enzyme found in the CRISPR gene-editing system. When a target such as a cancerous gene is detected by the enzyme, it begins shearing DNA from the electrode nonspecifically, like a lawnmower cutting grass, altering the electrical signal produced. One of the main limitations of this type of sensing technology is that the DNA that coats the electrode breaks down quickly, so the sensors can’t be stored for very long and their storage conditions must be tightly controlled, limiting where they can be used. In a new study, MIT researchers stabilized the DNA with a polymer coating, allowing the sensors to be stored for up to two months, even at high temperatures. After storage, the sensors were able to detect a prostate cancer gene that is often used to diagnose the disease.
Light and AI-driven flexible robot arm—a new control paradigm that does not require electronic components
A research team at Rice University has developed a flexible robotic arm capable of performing precise movements using only light and AI. The arm employs an innovative method that requires no internal electronic components or wiring, and is remotely controlled by laser light. The arm is made of a light-responsive azobenzene liquid crystal elastomer (LCE). Localized irradiation of blue laser light causes the material to contract and bend, enabling complex movements.Control is achieved using a spatial light modulator (SLM), with a neural network built using machine learning generating light patterns in real time according to the desired motion. This enables advanced movements such as obstacle avoidance and kicking a ball. Elizabeth Blackert, a PhD graduate, commented, “This is the first time in the world that real-time, reconfigurable automatic control has been achieved for light-responsive materials.”This technology is expected to have a wide range of applications, including implantable medical devices and industrial fields requiring delicate object handling. The lightweight structure, which eliminates electronic components, offers superior safety and adaptability, presenting a new design concept for flexible robot control.
Swedish company develops reusable pregnancy test
The femtech company Pharmista Technologies is developing an eco-friendly pregnancy test, after being admitted to the SmiLe’s incubator program. The pregnancy test is the most widely used home diagnostic test in the world. Alice Mattsson, business developer, and her co-founder, Robert Porter, a researcher and entrepreneur, are developing a pregnancy test that can be easily and hygienically reused. Customers just need to buy a monitor that contains chemical substances and electronics. Replaceable paper strips are loaded into the monitor before each test and the results appear on a display that provides a simpler reading than currently available tests. The paper strips do not contain environmentally hazardous substances and are made of cellulose that is easily biodegradable which makes the product eco-friendly.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
New plans for 'world-class' mental health hospital
Plans have been submitted for a £750m new mental health hospital and medical research campus. Oxford Health NHS Foundation Trust said Warneford Park, in Headington, Oxford, would "benefit patients" and support advances in "mental health and brain science". It added the new hospital would have modern inpatient facilities, emphasising "patient wellness and therapeutic spaces that connect with nature". The original hospital, which opened in 1826, is thought to be the oldest inpatient unit still in use across the NHS.
BBC
Alzheimer's: At-Home Brainwave Test Offers Early Warning
Asimple at-home brainwave test can detect signs of memory impairment linked to Alzheimer's disease years before clinical diagnosis is typically possible. This feat has been demonstrated by researchers from the universities of Bath and Bristol, in the U.K., who trialed the 'Fastball EEG' technology in patients' homes for the first time. The three-minute "passive test"—which records electrical activity in the brain while participants view a stream of images—can reliably identify memory problems in people with Mild Cognitive Impairment (MCI)—a condition that can lead to Alzheimer's. "We're missing the first 10 to 20 years of Alzheimer's with current diagnostic tools. Fastball offers a way to change that—detecting memory decline far earlier and more objectively, using a quick and passive test," said study author George Stothart, a cognitive neuroscientist at Bath, in a statement.
Newsweek
OMED breath biopsy is transforming disease detection
The OMED Health Breath Analyzer is a handheld sensor system designed for at-home collection and analysis of hydrogen and methane gases produced by the fermentation of undigested sugars by the gut microbiome. This portable device provides accurate, on-demand breath testing, making it a practical tool for both clinical trials and research applications. Paired with a user-friendly smartphone app, the Breath Analyzer allows individuals to log food intake and symptoms alongside their breath readings. This integrated data can then be accessed by researchers for longitudinal monitoring of gut microbiome responses across a range of clinical study designs. To ensure accuracy comparable to in-clinic hydrogen methane breath tests (HMBT), the OMED Health team conducted extensive validation. This included building an in-house synthetic breath rig and benchmarking the device against a clinically established HMBT system.
News-Medical.net
Capol acquires Blue Pacific Flavors to enhance global ingredients innovation
Capol, a subsidiary of the Freudenberg Group and a manufacturer of confectionery coatings, has announced its acquisition of Blue Pacific Flavors, a player in natural and organic flavour systems. The deal aims to create a formidable global leader in food ingredients, enhancing innovation and product development capabilities across the food and beverage industry. The acquisition is poised to leverage the complementary strengths of both companies, facilitating accelerated innovation in flavours and coatings while expanding customer reach across North America, Europe and Asia. With this merger, Capol aims to position itself at the forefront of market trends in health, wellness and indulgence categories, responding to the evolving demands of consumers and businesses alike.
FOODBEV MEDIA
Industrial biotechnology company enabling enzyme-based processes Providing high-performance enzymes that enable cost reduction and bio-based production
Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturing. The funding includes a $2.8M seed round led by Endurance28 with participation from Stray Dog Capital, 1Flourish, Range Ventures, 10VC, and Amplify plus $3.2M in nondilutive funding from the U.S. National Science Foundation (NSF) through the Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications (NSF CFIRE) initiative and an SBIR Phase II award. With this investment, Cascade will expand delivery of its breakthrough biocatalysts, giving industrial partners higher performing enzymes that cut costs and unlock biobased production.
PharmiWeb.com
Intravenous Maintenance Dosing of Early Alzheimer's Disease Treatment “Lecanemab®” (Lecanemab) Receives Approval in China
Eisai Co., Ltd. (Headquarters: Tokyo, Representative Executive Officer and CEO: Haruo Naito, hereinafter referred to as “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, USA, CEO: Christopher A. Viehbacher, hereinafter referred to as ‘Biogen’) have announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the humanized anti-human soluble amyloid beta (Aβ) aggregate monoclonal antibody “Lecembi®” (Chinese product name: "乐 Viehbacher; hereinafter “Biogen”) announce that the National Medical Products Administration (NMPA) of China has approved the once-every-four-weeks intravenous (IV) maintenance infusion of the humanized anti-human soluble amyloid beta (Aβ) aggregate monoclonal antibody “Lecanemab®” (Chinese product name: “乐意保®”; generic name: lecanemab).
Biogen
FDA grants 510(k) clearance for Cardiosense’s wearable sensor
The US Food and Drug Administration (FDA) has granted 510(k) clearance for CardioTag, Cardiosense’s multimodal, wearable sensor. Aimed at cardiac function monitoring, the device is said to capture high-fidelity electrocardiogram (ECG), seismocardiogram (SCG), and photoplethysmogram (PPG) signals. SCG is a technique that detects subtle chest wall vibrations linked to the heart’s mechanical activity.
Medical Device Network
Rethinking Adient Cell Culture for Scalable and Sustainable Biomanufacturing
This paper discusses the challenges and solutions related to the scalability and sustainability of Adient cell culture. Conventional T-flasks and roller bottles are not scalable, leading to increased labor costs and inconsistencies. Additionally, suspension culture using microcarriers may negatively impact cell behavior and product quality.New technologies maintain intercellular signaling and morphological consistency while improving labor efficiency and reproducibility. Sustainable technologies, such as biodegradable materials and additive manufacturing techniques, are gaining attention for their ability to reduce environmental impact while ensuring regulatory compliance. Going forward, scalable manufacturing processes and smart process integration will be essential.
Technology Networks
Wearable Sleep Monitoring Device May Improve Detection of Sleep Disorders
A new wearable sleep monitoring device developed by a research team at Northwestern University can be attached to the base of the neck to more accurately measure patients' sleep and improve the detection of sleep disorders. The device collects data such as breathing, heart rate, and body temperature, and provides sleep scores and analysis results to patients' smartphones or tablets through the machine learning model LMA-SleepNet.Additionally, compared to traditional devices worn on the wrist or finger, this device can collect more sleep data and has the ability to accurately analyze breathing patterns. This study was published in the Proceedings of the National Academy of Sciences (PNAS).
Feinberg School of Medicine News Center
From Sleep Tech to Health Check Integration: The Evolution of Vital Sensors Measuring Heart Rate and Breathing
The application areas for Sumitomo Riko's developed vital sensor “Monilife™ Wellness” are expanding. Following its initial introduction in capsule hotels in 2021, a new service combining sleep analysis and health checkups is scheduled to launch. This initiative, bridging sleep tech and preventive healthcare, is drawing significant attention. In August 2024, Nine Hours will install “Monilife Wellness” in all 70 beds at its new “Shinagawa Station Sleep Lab.” Cumulative installations have now surpassed 450 units. The sensor utilizes piezoelectric technology based on the flexible conductive rubber “Smart Rubber® (SR),” featuring a unique formulation balance that achieves both softness and conductivity.It detects minute vibrations from heartbeat and respiratory components without requiring wearable devices. Guests receive sleep measurement and analysis, later reviewing their condition via a report. Moving forward, Nine Hours and Kinki Health Center (KKC) will partner to launch a “Sleep Analysis + Health Checkup” service in Tokyo. Users will stay at the capsule hotel to collect sleep data, which will be combined with a subsequent health checkup for a comprehensive evaluation. This approach requires less effort than traditional testing and enables data collection in a natural state. The “Monilife” series is deployed for both medical and non-medical devices. It has been utilized in studies such as detecting worsening conditions in heart failure patients during home care and researching drowsiness warning signs for drivers. Sumitomo Riko, aiming to become a “leading company that continuously provides solutions to social issues, starting from the power of science and technology,” as stated in its management vision for its 100th anniversary in 2029, is poised to further accelerate its business expansion in the healthcare field.
DxMedical Cloud™︎
MIT engineers develop electrochemical sensors for cheap, disposable diagnostics
Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such as influenza and HIV. These electrochemical sensors make use of a DNA-chopping enzyme found in the CRISPR gene-editing system. When a target such as a cancerous gene is detected by the enzyme, it begins shearing DNA from the electrode nonspecifically, like a lawnmower cutting grass, altering the electrical signal produced. One of the main limitations of this type of sensing technology is that the DNA that coats the electrode breaks down quickly, so the sensors can’t be stored for very long and their storage conditions must be tightly controlled, limiting where they can be used. In a new study, MIT researchers stabilized the DNA with a polymer coating, allowing the sensors to be stored for up to two months, even at high temperatures. After storage, the sensors were able to detect a prostate cancer gene that is often used to diagnose the disease.
MIT News
Light and AI-driven flexible robot arm—a new control paradigm that does not require electronic components
A research team at Rice University has developed a flexible robotic arm capable of performing precise movements using only light and AI. The arm employs an innovative method that requires no internal electronic components or wiring, and is remotely controlled by laser light. The arm is made of a light-responsive azobenzene liquid crystal elastomer (LCE). Localized irradiation of blue laser light causes the material to contract and bend, enabling complex movements.Control is achieved using a spatial light modulator (SLM), with a neural network built using machine learning generating light patterns in real time according to the desired motion. This enables advanced movements such as obstacle avoidance and kicking a ball. Elizabeth Blackert, a PhD graduate, commented, “This is the first time in the world that real-time, reconfigurable automatic control has been achieved for light-responsive materials.”This technology is expected to have a wide range of applications, including implantable medical devices and industrial fields requiring delicate object handling. The lightweight structure, which eliminates electronic components, offers superior safety and adaptability, presenting a new design concept for flexible robot control.
DxMedical Cloud™︎
Swedish company develops reusable pregnancy test
The femtech company Pharmista Technologies is developing an eco-friendly pregnancy test, after being admitted to the SmiLe’s incubator program. The pregnancy test is the most widely used home diagnostic test in the world. Alice Mattsson, business developer, and her co-founder, Robert Porter, a researcher and entrepreneur, are developing a pregnancy test that can be easily and hygienically reused. Customers just need to buy a monitor that contains chemical substances and electronics. Replaceable paper strips are loaded into the monitor before each test and the results appear on a display that provides a simpler reading than currently available tests. The paper strips do not contain environmentally hazardous substances and are made of cellulose that is easily biodegradable which makes the product eco-friendly.
Femtech World